[{"Assets_0_Q1_USD":"34834000000.0","CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q1_USD":"0.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"1.05","EarningsPerShareDiluted_1_Q1_USD":"1.04","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","MinorityInterest_0_Q1_USD":"99000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"1390000000.0","NetIncomeLoss_1_Q1_USD":"1710000000.0","OfficialName":"Bristol-Myers Squibb Company Common Stock","ProfitLoss_1_Q1_USD":"1715000000.0","RevenuesConverted_1_Q1_USD":"5920000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"15317000000.0","StockholdersEquity_0_Q1_USD":"15218000000.0","Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"1637000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"1634000000.0","filed":"20190425","footnote":null,"form":"10-Q","fp":"Q1","fy":"2019.0","name":"BRISTOL MYERS SQUIBB CO","period":"20190331","qtrs":"0","uom":"USD"}]